New Partnership Between Genome Canada and adMare BioInnovations to Drive Commercialization of Genomics Solutions in Healthcare

In celebration of Global Biotech Week, at the national BIONATION 2022 conference, the leaders of Genome Canada and adMare BioInnovations announced a new strategic partnership to support the translation of genomics research into commercialization opportunities in healthcare...READ MORE

Canadian Biotech Industry Recognizes Top Performers (SEP 28)

BIOTECanada is pleased to announce the 2022 winners in four BIOTECanada Gold Leaf Award categories - Established Biotech Company of the Year, Game Changing Industry Leadership, Ecosystem Builder, and Promising Health Biotech Company of the Year...READ MORE

New Cooperation Enables Evonik to Provide Tire Industry with Silica Made from Biobased Raw Materials

Evonik, one of the world’s leading silica producers, has entered a strategic cooperation with the Pörner Group, Austria and Phichit Bio Power Co., Ltd., Thailand, to supply sustainable ULTRASIL® precipitated silica to tire manufacturers. The key raw material for the sustainable silica is sodium silicate, which is derived from rice husk ash, an agricultural waste product, and produced exclusively with green energy...READ MORE

Merck’s KEYTRUDA® (pembrolizumab) Receives Four New Approvals in Japan, Including in High-Risk Early-Stage Triple-Negative Breast Cancer (TNBC) 

Merck, known as MSD outside of the United States and Canada, announced that KEYTRUDA, Merck’s anti-PD-1 therapy, received four new approvals from Japan’s Ministry of Health, Labor and Welfare. KEYTRUDA now approved for 23 uses in 13 different types of cancer in Japan...READ MORE

BioTalent Canada Announces its Board of Directors for 2022-2023

Following their Annual General Meeting, BioTalent Canada has broadened its leadership team with the announcement of 16 new and returning Board Members. Under the guidance of returning Chair, Reg Joseph, CEO, Health Cities, the Board is well-positioned to support the talent within one of Canada’s most vital sectors...READ MORE

Pfizer and BioNTech Submit Application to U.S. FDA for Emergency Use Authorization of Omicron BA.4/BA.5-Adapted Bivalent Vaccine Booster in Children 5 Through 11 Years of Age

Pfizer Inc. announced they have completed a submission to the U.S. Food and Drug Administration requesting Emergency Use Authorization of a 10-µg booster dose of the companies’ Omicron BA.4/BA.5-adapted bivalent COVID-19 vaccine for children ages 5 through 11 years of age. The request for Emergency Use Authorization of the Omicron BA.4/BA.5-adapted bivalent vaccine in this age group is supported by safety and immunogenicity data from the companies’ bivalent Omicron BA.1-adapted vaccine...READ MORE

Precision NanoSystems and Replicate Bioscience in Licensing Deal to Scale Up Genomic Medicines

In a move that signifies the heightened focus on mRNA as a key tool in human health, Precision NanoSystems and Replicate Bioscience will enter a licensing agreement to accelerate the creation, scale-up, and delivery of self-replicating RNA therapies...READ MORE

Qu Biologics to Launch Phase 2B Clinical Trial to Assess Reduction of Postoperative Immune Suppression and Disease Progression in Patients with Late-Stage Colorectal Cancer

Qu Biologics Inc., a clinical stage biopharmaceutical company developing Site Specific Immunomodulators (SSIs), a novel immunotherapy platform designed to restore innate immune function, announced it has received Health Canada clearance (No Objection Letter) and institutional-level ethics approval to proceed with a randomized placebo-controlled Phase II multicenter trial...READ MORE

InMed Pharmaceuticals Reports Full Year Fiscal 2022 Financial Results and Provides Business Update

InMed Pharmaceuticals Inc., a leader in the pharmaceutical research, development and manufacturing of rare cannabinoids and cannabinoid analogs, reported financial results for the fiscal year ended June 30, 2022...READ MORE

New Joint Report on Pan-Canadian Population Cohorts Charts Course for Improved Health Outcomes

Genome Canada and the Canadian Institutes of Health Research released a joint report, Enhancing Canada’s Population Cohort Environment, with 11 recommendations to strengthen Canada’s health data and research outcomes and drive greater benefits for those who live in Canada...READ MORE

Canadian Scientists Lead Nobel Prize Medicine Race for Developing mRNA Vaccine

This year, the Nobel Prize in physiology or medicine will be awarded on Oct. 3. Canada will be in the spotlight again, thanks to Canadian scientists’ involvement with mRNA vaccine development. The Canada Gairdner International Award, offered to five researchers who have excelled in the medical sciences, is often considered a predictor of the Nobel Prize...READ MORE

Scientist – Predictive Pharmacokinetic (PK) Modelling

In this vital role you will work with a multidisciplinary team to develop antibody dose and exposure-response relationships for multiple programs and use this information to help establish antibody affinity and potency design goals through in silico pharmacokinetic modelling. This modelling will have inherent assumptions, so the candidate will have the opportunity to perform pre-clinical experiments to help refine these assumptions through the biological or biophysical characterization of the therapeutic targets or antibody panels. Well-suited applicants will have a solid understanding of the PK principles and modelling, as well as a familiarity with modelling software. You should have a passion for tackling difficult research challenges and a positive approach to working in a team-based research environment.

LEARN MORE

Senior Statistical Programmer

Zymeworks is a clinical-stage biopharmaceutical company dedicated to the discovery, development and commercialization of next-generation bispecific and multifunctional biotherapeutics, initially focused on the treatment of cancer. Zymeworks’ suite of complementary therapeutic platforms and its fully-integrated drug development engine provide the flexibility and compatibility to precisely engineer and develop highly-differentiated product candidates.

This position will report to the V.P. of Biometrics and will be based in our offices in Vancouver BC.

LEARN MORE

Research & Development Chemist

Alpha-9 is seeking a Research & Development Chemist to join our growing organization. The ideal candidate will have experience with solid-phase peptide synthesis, and preferably with radiopharmaceutical development. This person will be responsible for designing, planning and synthesizing peptides/peptidomimetic building blocks and precursors for radiopharmaceutical product candidates. 

We are an early-stage company, so you will have the opportunity to participate cross-functionally and contribute to the build-out and set-up of new laboratory facilities. The ideal candidate will have multi-tasking ability and a desire to strive in a fast-paced environment. 

LEARN MORE

The Canadian Alliance for Skills and Training in Life Sciences (CASTL) provides industry-informed

technical skills development and training specializing in biopharmaceutical manufacturing. CASTL is the exclusive provider of the National Institute for Bioprocessing Research and Training (NIBRT) licensed training programs in Canada. Based in Ireland, NIBRT develops and delivers state-of-the-art training and education programs for the world’s leading biopharmaceutical manufacturing companies. CASTL is supported by National Lead Partner adMare BioInnovations and its adMare Academy. The adMare Academy is dedicated to providing the specialized training required to foster the next generation of highly qualified personnel who will drive the growth of Canadian life science companies. 

Visit Website

The British Columbia Securities Commission (BCSC) strives to make the investment markets benefit the public – enabling people to achieve their financial goals, enterprises to grow, and British Columbia to thrive.

Through smart rules, diligent oversight, strong enforcement and reliable guidance, we act as guardians of the province’s investment marketplace, striving to make BC a place where people can invest with confidence and companies can flourish.

Visit Website